Latest filing published 30 Nov 2021 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €842k.
This profile gathers the share dealings of Steven Daniel Miller in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Over a trading history stretching from 17 March 2021 to 30 November 2021, the count stands at 4 filings.
Purchases make up the whole of the open-market record (2 purchases, €1.0M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise.
The record was last updated on 30 November 2021 with an open-market purchase (€842k) in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations